Hunan Jingfeng Pharmaceutical (000908) — Long-term Investment Intensity
Hunan Jingfeng Pharmaceutical (000908) has a Long-term Investment Intensity of 6.0% as of September 2019. Long-term investments of CN¥342.33 Million represent 6.0% of total assets of CN¥5.74 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Hunan Jingfeng Pharmaceutical for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hunan Jingfeng Pharmaceutical Long-term Investment Intensity (2015–2018)
This chart shows how Hunan Jingfeng Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 6.0%, reflecting long-term investments of CN¥342.33 Million against total assets of CN¥5.74 Billion CNY. Also explore Hunan Jingfeng Pharmaceutical balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Hunan Jingfeng Pharmaceutical (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hunan Jingfeng Pharmaceutical from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 000908 market cap.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 6.6% | CN¥343.64 Million | CN¥5.23 Billion | ▼ -0.4 pp |
| 2017 | 7.0% | CN¥340.28 Million | CN¥4.87 Billion | ▲ +2.7 pp |
| 2016 | 4.3% | CN¥220.60 Million | CN¥5.13 Billion | ▼ -2.6 pp |
| 2015 | 6.9% | CN¥235.86 Million | CN¥3.44 Billion | — |